| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| ABBV 艾伯維 | 18,067,000,000.0 | 38,871,000,000.0 | 148,874,000,000.0 |
| AZN AstraZeneca PLC | 7,841,000,000.0 | 25,594,000,000.0 | 102,293,000,000.0 |
| BMY 施貴寶 | 9,330,000,000.0 | 28,669,000,000.0 | 99,031,000,000.0 |
| AMGN 美國安進 | 9,708,000,000.0 | 28,029,000,000.0 | 92,980,000,000.0 |
| GILD 吉利德科學 | 4,718,000,000.0 | 14,041,000,000.0 | 56,292,000,000.0 |
| REGN 雷傑納榮製藥 | 2,602,000,000.0 | 18,871,500,000.0 | 34,369,600,000.0 |
| BIIB Biogen Inc | 1,074,400,000.0 | 6,756,200,000.0 | 26,567,600,000.0 |
| VRTX 福泰製藥 | 9,158,000,000.0 | 13,288,700,000.0 | 23,917,400,000.0 |
| MRNA 莫德納 | 2,051,000,000.0 | 9,600,000,000.0 | 16,729,000,000.0 |
| SVA Sinovac Biotech Ltd | 1,270,131,000.0 | 11,830,556,000.0 | 13,657,974,000.0 |
| BIO.B Bio Rad Laboratories Inc | 433,280,000.0 | 3,060,936,000.0 | 12,609,893,000.0 |
| ILMN Illumina Inc | 1,108,000,000.0 | 2,583,000,000.0 | 10,040,000,000.0 |
| ROIV Roivant Sciences Ltd | 6,670,810,000.0 | 6,806,733,000.0 | 7,312,679,000.0 |
| INCY 英賽德 | 3,346,204,000.0 | 4,849,091,000.0 | 7,135,605,000.0 |
| BMRN Biomarin Pharmaceutical Inc | 716,019,000.0 | 2,985,012,000.0 | 6,872,673,000.0 |
| EXAS Exact Sciences Corp | 347,487,000.0 | 1,120,270,000.0 | 6,376,321,000.0 |
| QGEN Qiagen NV | 668,084,000.0 | 2,147,560,000.0 | 6,115,190,000.0 |
| ALNY Alnylam Pharmaceuticals Inc | 681,879,000.0 | 2,988,607,000.0 | 3,824,386,000.0 |
| SRPT Sarepta Therapeutics Inc | 427,290,000.0 | 2,464,865,000.0 | 3,224,385,000.0 |
| RGEN Repligen Corp | 780,617,000.0 | 1,133,018,000.0 | 2,849,269,000.0 |
| EXEL Exelixis Inc | 259,561,000.0 | 1,292,429,000.0 | 2,803,752,000.0 |
| TECH Bio-Techne Corp | 139,915,000.0 | 610,650,000.0 | 2,721,170,000.0 |
| CRSP CRISPR Therapeutics AG | 707,427,000.0 | 2,119,624,000.0 | 2,439,017,000.0 |
| ALKS Alkermes Plc | 420,753,000.0 | 1,468,825,000.0 | 2,123,896,000.0 |
| PCVX Vaxcyte Inc | 611,512,000.0 | 1,517,072,000.0 | 2,091,305,000.0 |
| HALO Halozyme Therapeutics Inc | 164,627,000.0 | 873,584,000.0 | 1,841,527,000.0 |
| EBS Emergent BioSolutions Inc | 78,500,000.0 | 682,400,000.0 | 1,803,600,000.0 |
| VIR Vir Biotechnology Inc | 160,711,000.0 | 1,213,097,000.0 | 1,793,969,000.0 |
| LEGN Legend Biotech Corp | 897,571,000.0 | 1,413,792,000.0 | 1,775,107,000.0 |
| GH Guardant Health Inc | 1,129,257,000.0 | 1,308,546,000.0 | 1,704,598,000.0 |
| NEO Neogenomics Inc | 331,914,000.0 | 573,896,000.0 | 1,640,339,000.0 |
| DNA Ginkgo Bioworks Holdings Inc | 840,440,000.0 | 903,020,000.0 | 1,581,761,000.0 |
| DNLI Denali Therapeutics Inc | 60,574,000.0 | 973,575,000.0 | 1,581,091,000.0 |
| CERT Certara Inc | 224,776,000.0 | 328,457,000.0 | 1,542,378,000.0 |
| ABCL Abcellera Biologics Inc | 123,572,000.0 | 813,948,000.0 | 1,463,096,000.0 |
| MRVI Maravai LifeSciences Holdings Inc | 561,691,000.0 | 667,884,000.0 | 1,444,641,000.0 |
| BEAM Beam Therapeutics Inc | 287,848,000.0 | 1,121,710,000.0 | 1,359,796,000.0 |
| NVAX Novavax Inc | 480,586,000.0 | 727,120,000.0 | 1,353,534,000.0 |
| RARE Ultragenyx Pharmaceutical Inc | 112,250,000.0 | 595,967,000.0 | 1,307,080,000.0 |
| RCUS Arcus Biosciences Inc | 185,000,000.0 | 1,064,000,000.0 | 1,293,000,000.0 |
| HCM HUTCHMED (China) Ltd | 283,589,000.0 | 1,096,839,000.0 | 1,279,773,000.0 |
| NTLA Intellia Therapeutics Inc | 171,979,000.0 | 884,043,000.0 | 1,259,589,000.0 |
| ARVN Arvinas Inc | 88,000,000.0 | 1,190,300,000.0 | 1,212,600,000.0 |
| INSM Insmed Inc | 595,729,000.0 | 758,722,000.0 | 1,159,095,000.0 |
| MYGN Myriad Genetics Inc | 96,900,000.0 | 290,300,000.0 | 1,110,500,000.0 |
| BPMC Blueprint Medicines Corp | 113,326,000.0 | 776,602,000.0 | 1,038,475,000.0 |
| ZLAB Zai Lab Ltd | 650,780,000.0 | 888,640,000.0 | 988,437,000.0 |
| DVAX Dynavax Technologies Corp | 132,033,000.0 | 851,286,000.0 | 986,565,000.0 |
| VKTX Viking Therapeutics Inc | 195,579,000.0 | 966,335,000.0 | 967,518,000.0 |
| XENE Xenon Pharmaceuticals Inc | 148,643,000.0 | 644,962,000.0 | 964,798,000.0 |
| IDYA IDEAYA Biosciences Inc | 108,345,000.0 | 709,353,000.0 | 961,527,000.0 |
| RNA Avidity Biosciences Inc | 471,400,000.0 | 934,474,000.0 | 951,474,000.0 |
| ANIP ANI Pharmaceuticals Inc | 228,597,000.0 | 540,557,000.0 | 914,524,000.0 |
| LGND Ligand Pharmaceuticals Inc | 50,093,000.0 | 368,913,000.0 | 913,869,000.0 |
| AKRO Akero Therapeutics Inc | 623,854,000.0 | 911,280,000.0 | 912,243,000.0 |
| AUTL Autolus Therapeutics PLC | 758,529,000.0 | 804,298,000.0 | 901,436,000.0 |
| IOVA Iovance Biotherapeutics Inc | 134,188,000.0 | 385,533,000.0 | 869,830,000.0 |
| CLDX Celldex Therapeutics Inc | 115,077,000.0 | 835,324,000.0 | 868,847,000.0 |
| KYMR Kymera Therapeutics Inc | 93,510,000.0 | 537,253,000.0 | 868,251,000.0 |
| ACAD ACADIA Pharmaceuticals Inc | 204,745,000.0 | 675,296,000.0 | 855,103,000.0 |
| HRMY Harmony Biosciences Holdings Inc | 332,981,000.0 | 479,503,000.0 | 846,985,000.0 |
| APLS Apellis Pharmaceuticals Inc | 325,923,000.0 | 811,428,000.0 | 831,930,000.0 |
| KRYS Krystal Biotech Inc | 358,328,000.0 | 587,909,000.0 | 818,355,000.0 |
| CYTK Cytokinetics Inc | 119,976,000.0 | 638,704,000.0 | 808,082,000.0 |
| AMRN Amarin Corporation PLC | 213,944,000.0 | 687,932,000.0 | 790,013,000.0 |
| ACLX Arcellx Inc | 154,574,000.0 | 588,733,000.0 | 779,695,000.0 |
| QURE Uniqure NV | 243,062,000.0 | 596,003,000.0 | 770,050,000.0 |
| CHRS Coherus BioSciences Inc | 259,775,000.0 | 627,477,000.0 | 763,545,000.0 |
| ITCI Intra-Cellular Therapies Inc | 139,819,000.0 | 690,527,000.0 | 747,036,000.0 |
| FOLD Amicus Therapeutics Inc | 209,761,000.0 | 431,239,000.0 | 721,789,000.0 |
| NUVL Nuvalent Inc | 98,515,000.0 | 699,494,000.0 | 708,466,000.0 |
| TWST Twist Bioscience Corp | 243,348,000.0 | 371,869,000.0 | 702,846,000.0 |
| JANX Janux Therapeutics Inc | 212,803,000.0 | 658,666,000.0 | 688,984,000.0 |
| MORF Morphic Holding Inc | 44,410,000.0 | 675,941,000.0 | 682,765,000.0 |
| SANA Sana Biotechnology Inc | 177,054,000.0 | 321,263,000.0 | 681,377,000.0 |
| MESO Mesoblast Ltd | 77,144,000.0 | 85,154,000.0 | 670,285,000.0 |
| IMVT Immunovant Inc | 635,365,000.0 | 665,770,000.0 | 666,365,000.0 |
| TVTX Travere Therapeutics Inc | 43,251,000.0 | 481,076,000.0 | 663,547,000.0 |
| SWTX SpringWorks Therapeutics Inc | 118,031,000.0 | 471,798,000.0 | 656,832,000.0 |
| VNDA Vanda Pharmaceuticals Inc | 125,158,000.0 | 439,425,000.0 | 652,682,000.0 |
| MIRM Mirum Pharmaceuticals Inc | 302,843,000.0 | 389,465,000.0 | 651,962,000.0 |
| ALEC Alector Inc | 72,552,000.0 | 581,390,000.0 | 635,494,000.0 |
| VRDN Viridian Therapeutics Inc | 91,641,000.0 | 626,818,000.0 | 630,381,000.0 |
| ITOS Iteos Therapeutics Inc | 146,648,000.0 | 480,386,000.0 | 629,769,000.0 |
| PTGX Protagonist Therapeutics Inc | 172,568,000.0 | 627,553,000.0 | 629,276,000.0 |
| RGNX Regenxbio Inc | 112,975,000.0 | 395,418,000.0 | 629,215,000.0 |
| PRTA Prothena Corporation PLC | 546,512,000.0 | 565,868,000.0 | 623,194,000.0 |
| ADPT Adaptive Biotechnologies Corp | 71,233,000.0 | 374,034,000.0 | 620,323,000.0 |
| NUVB Nuvation Bio Inc | 34,510,000.0 | 608,055,000.0 | 613,125,000.0 |
| ME 23andMe Holding Co. | 242,418,000.0 | 309,959,000.0 | 608,211,000.0 |
| ALLO Allogene Therapeutics Inc | 51,039,000.0 | 395,364,000.0 | 586,350,000.0 |
| ETNB 89Bio Inc | 217,573,000.0 | 574,782,000.0 | 577,322,000.0 |
| NKTX Nkarta Inc | 250,285,000.0 | 442,781,000.0 | 576,936,000.0 |
| FATE Fate Therapeutics Inc | 121,322,000.0 | 394,375,000.0 | 569,892,000.0 |
| ZNTL Zentalis Pharmaceuticals Inc | 37,616,000.0 | 503,806,000.0 | 557,479,000.0 |
| KURA Kura Oncology Inc | 41,506,000.0 | 537,835,000.0 | 553,908,000.0 |
| EWTX Edgewise Therapeutics Inc | 30,264,000.0 | 541,427,000.0 | 553,806,000.0 |
| ZYME Zymeworks Inc | 114,814,000.0 | 393,820,000.0 | 553,752,000.0 |
| AVIR Atea Pharmaceuticals Inc | 160,910,000.0 | 548,764,000.0 | 553,029,000.0 |
| BCYC Bicycle Therapeutics PLC | 456,997,000.0 | 515,962,000.0 | 547,143,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例